Immune recovery uveitis - 05/09/11
Abstract |
%In March 1998, the American Journal of Ophthalmology featured a cluster of publications1, 2, 3 that focused on the emerging problem of intraocular inflammation in patients with human immunodeficiency virus disease. Included was one of the early descriptions of “immune recovery uveitis,” a condition in which heightened intraocular inflammatory reactions, attributable to the improved immune function associated with new potent antiretroviral therapies, occurs in some patients with preexisting cytomegalovirus retinitis.3, 4 Now, 2 years later, immune recovery uveitis is believed to be the leading cause of severe, new vision loss in patients with cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.5 Nevertheless, the disorder remains poorly understood. A recently published study6 and two additional articles7,8 in this issue of the journal address some of the questions that have arisen about immune recovery uveitis, and highlight many of the problems that remain to be solved.
El texto completo de este artículo está disponible en PDF.| This study was supported in part by Research to Prevent Blindness, Inc, New York, New York, and the David May II Endowed Professorship (Dr Holland). Dr Holland is the recipient of a Research to Prevent Blindness–Lew R. Wasserman Merit Award. |
Vol 130 - N° 1
P. 103-106 - juillet 2000 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?
